# Stablecoin Development Corp: financial statements, quarterly

SDEV · NYSE · CIK 1389545 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sdev.md) · [Financials](/companies/sdev/financials.md) · [Filings](/companies/sdev/filings.md) · [Insiders](/companies/sdev/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sdev/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.1 d](/filings/0001437749-25-010730.md) | [2.6](/filings/0001437749-24-015679.md) | [2.4](/filings/0001437749-24-026386.md) | [0.0](/filings/0001437749-25-033852.md) | [9.8 d](/filings/0001437749-25-010730.md) | [0.0](/filings/0001437749-26-017406.md) | [0.0](/filings/0001437749-26-025065.md) | [0.0](/filings/0001437749-26-033940.md) | not reported | [2.5](/filings/0001437749-26-017406.md) | [2.2](/filings/0001437749-26-025065.md) | [2.1](/filings/0001437749-26-033940.md) |
| Cost of revenue | $m | [1.0 d](/filings/0001437749-25-010730.md) | [0.8](/filings/0001437749-24-015679.md) | [0.8](/filings/0001437749-24-026386.md) | [0.0](/filings/0001437749-25-033852.md) | [3.3 d](/filings/0001437749-25-010730.md) | not reported | not reported | [0.5](/filings/0001437749-25-033852.md) | not reported | not reported | not reported | not reported |
| Gross profit | $m | [1.1 d](/filings/0001437749-25-010730.md) | [1.8](/filings/0001437749-24-015679.md) | [1.6](/filings/0001437749-24-026386.md) | [0.0](/filings/0001437749-25-033852.md) | [6.5 d](/filings/0001437749-25-010730.md) | not reported | not reported | [0.0](/filings/0001437749-25-033852.md) | not reported | not reported | not reported | not reported |
| Research and development | $m | [(0.0) d](/filings/0001437749-25-010730.md) | [0.0](/filings/0001437749-24-015679.md) | [0.0](/filings/0001437749-24-026386.md) | [0.0](/filings/0001437749-24-033919.md) | [0.0 d](/filings/0001437749-25-010730.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.0) d](/filings/0001437749-25-010730.md) | [(2.3)](/filings/0001437749-25-017064.md) | [(1.6)](/filings/0001437749-25-026970.md) | [(1.7)](/filings/0001437749-25-033852.md) | [(1.8) d](/filings/0001437749-26-013913.md) | [(3.3)](/filings/0001437749-26-017406.md) | [(1.9)](/filings/0001437749-26-025065.md) | [(1.3)](/filings/0001437749-26-033940.md) | [(2.0) d](/filings/0001437749-26-013913.md) | [22.3](/filings/0001437749-26-017406.md) | [(53.8)](/filings/0001437749-26-025065.md) | [56.0](/filings/0001437749-26-033940.md) |
| Income tax | $m | not reported | [0.0](/filings/0001437749-25-017064.md) | [0.0](/filings/0001437749-25-026970.md) | [0.0](/filings/0001437749-25-033852.md) | [0.0 d](/filings/0001437749-26-013913.md) | [0.0](/filings/0001437749-26-017406.md) | [0.0](/filings/0001437749-26-025065.md) | [0.0](/filings/0001437749-26-033940.md) | [0.0 d](/filings/0001437749-26-013913.md) | [3.5](/filings/0001437749-26-017406.md) | [(3.5)](/filings/0001437749-26-025065.md) | [5.6](/filings/0001437749-26-033940.md) |
| Net income | $m | [(4.1) d](/filings/0001437749-25-010730.md) | [(3.2)](/filings/0001437749-25-033852.md) | [(1.6)](/filings/0001437749-25-033852.md) | [(1.2)](/filings/0001437749-25-033852.md) | [(1.2) d](/filings/0001437749-26-013913.md) | [7.7](/filings/0001437749-26-033940.md) | [(1.9)](/filings/0001437749-26-033940.md) | [(1.3)](/filings/0001437749-26-033940.md) | [(635) d](/filings/0001437749-26-013913.md) | [552](/filings/0001437749-26-033940.md) | [(41.1)](/filings/0001437749-26-033940.md) | [50.4](/filings/0001437749-26-033940.md) |
| Diluted EPS | $ per share | not reported | [(29.95)](/filings/0001437749-25-017064.md) | [(1.37)](/filings/0001437749-25-026970.md) | [(1.92)](/filings/0001437749-25-033852.md) | not reported | [7.08](/filings/0001437749-26-017406.md) | [(1.65)](/filings/0001437749-26-025065.md) | [(1.10)](/filings/0001437749-26-033940.md) | not reported | [3.33](/filings/0001437749-26-017406.md) | [(1.32)](/filings/0001437749-26-025065.md) | [0.23](/filings/0001437749-26-033940.md) |
| Basic EPS | $ per share | not reported | [(29.95)](/filings/0001437749-25-017064.md) | [(1.37)](/filings/0001437749-25-026970.md) | [(1.92)](/filings/0001437749-25-033852.md) | not reported | [7.22](/filings/0001437749-26-017406.md) | [(1.65)](/filings/0001437749-26-025065.md) | [(1.10)](/filings/0001437749-26-033940.md) | not reported | [21.23](/filings/0001437749-26-017406.md) | [(1.32)](/filings/0001437749-26-025065.md) | [0.23](/filings/0001437749-26-033940.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.9](/filings/0001437749-25-010730.md) | [1.8](/filings/0001437749-24-015679.md) | [0.8](/filings/0001437749-24-026386.md) | [0.8](/filings/0001437749-24-033919.md) | [0.4](/filings/0001437749-26-013913.md) | [8.5](/filings/0001437749-25-017064.md) | [5.3](/filings/0001437749-25-026970.md) | [2.3](/filings/0001437749-25-033852.md) | [8.0](/filings/0001437749-26-033940.md) | [18.4](/filings/0001437749-26-017406.md) | [7.0](/filings/0001437749-26-025065.md) | [7.2](/filings/0001437749-26-033940.md) |
| Current assets | $m | [7.2](/filings/0001437749-25-010730.md) | [3.6](/filings/0001437749-24-015679.md) | [2.3](/filings/0001437749-24-026386.md) | [2.3](/filings/0001437749-24-033919.md) | [1.9](/filings/0001437749-26-013913.md) | [9.0](/filings/0001437749-25-017064.md) | [6.1](/filings/0001437749-25-026970.md) | [2.9](/filings/0001437749-25-033852.md) | [8.7](/filings/0001437749-26-033940.md) | [19.1](/filings/0001437749-26-017406.md) | [8.1](/filings/0001437749-26-025065.md) | [7.8](/filings/0001437749-26-033940.md) |
| Total assets | $m | [9.0](/filings/0001437749-25-010730.md) | [5.4](/filings/0001437749-24-015679.md) | [3.9](/filings/0001437749-24-026386.md) | [3.9](/filings/0001437749-24-033919.md) | [3.4](/filings/0001437749-26-013913.md) | [9.9](/filings/0001437749-25-017064.md) | [6.9](/filings/0001437749-25-026970.md) | [3.5](/filings/0001437749-25-033852.md) | [9.0](/filings/0001437749-26-033940.md) | [180](/filings/0001437749-26-017406.md) | [128](/filings/0001437749-26-025065.md) | [188](/filings/0001437749-26-033940.md) |
| Current liabilities | $m | [4.3](/filings/0001437749-25-010730.md) | [3.9](/filings/0001437749-24-015679.md) | [3.6](/filings/0001437749-24-026386.md) | [2.0](/filings/0001437749-24-033919.md) | [2.8](/filings/0001437749-26-013913.md) | [3.1](/filings/0001437749-25-017064.md) | [2.1](/filings/0001437749-25-026970.md) | [1.4](/filings/0001437749-25-033852.md) | [1.1](/filings/0001437749-26-033940.md) | [3.6](/filings/0001437749-26-017406.md) | [0.3](/filings/0001437749-26-025065.md) | [0.5](/filings/0001437749-26-033940.md) |
| Total liabilities | $m | [5.7](/filings/0001437749-25-010730.md) | [5.2](/filings/0001437749-24-015679.md) | [4.5](/filings/0001437749-24-026386.md) | [2.8](/filings/0001437749-24-033919.md) | [3.6](/filings/0001437749-26-013913.md) | [3.7](/filings/0001437749-25-017064.md) | [2.7](/filings/0001437749-25-026970.md) | [1.9](/filings/0001437749-25-033852.md) | [641](/filings/0001437749-26-033940.md) | [40.9](/filings/0001437749-26-017406.md) | [0.3](/filings/0001437749-26-025065.md) | [6.1](/filings/0001437749-26-033940.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3.3](/filings/0001437749-26-013913.md) | [0.2](/filings/0001437749-25-033852.md) | [(0.6)](/filings/0001437749-25-033852.md) | [1.1](/filings/0001437749-25-033852.md) | [(0.1)](/filings/0001437749-26-033940.md) | [6.2](/filings/0001437749-26-033940.md) | [4.2](/filings/0001437749-26-033940.md) | [1.1](/filings/0001437749-26-033940.md) | [(632)](/filings/0001437749-26-033940.md) | [139](/filings/0001437749-26-033940.md) | [127](/filings/0001437749-26-033940.md) | [182](/filings/0001437749-26-033940.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(592) d](/filings/0001437749-24-009417.md) | [(1,979)](/filings/0001437749-25-017064.md) | [(1,400) d](/filings/0001437749-25-026970.md) | [(2,442) d](/filings/0001437749-25-033852.md) | [(1,676) d](/filings/0001437749-26-013913.md) | [(1,324)](/filings/0001437749-26-017406.md) | [(2,524) d](/filings/0001437749-26-025065.md) | [(1,981) d](/filings/0001437749-26-033940.md) | [(2,601) d](/filings/0001437749-26-013913.md) | [(1,804)](/filings/0001437749-26-017406.md) | [(5,965) d](/filings/0001437749-26-025065.md) | [(1,120) d](/filings/0001437749-26-033940.md) |
| Capital expenditure | $k | [3.0 d](/filings/0001437749-25-010730.md) | [2.0](/filings/0001437749-25-017064.md) | [0.0 d](/filings/0001437749-25-026970.md) | [0.0 d](/filings/0001437749-25-033852.md) | [4.0 d](/filings/0001437749-25-010730.md) | [0.0](/filings/0001437749-25-017064.md) | [0.0 d](/filings/0001437749-25-026970.md) | [0.0 d](/filings/0001437749-25-033852.md) | not reported | not reported | not reported | not reported |
| Dividends paid | $k | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-013913.md) | not reported | not reported | not reported | [17.0 d](/filings/0001437749-26-013913.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q3 FY2020 (2020-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.6](/filings/0001437749-19-015688.md) | [23.2](/filings/0001437749-20-023620.md) | [40.1](/filings/0001437749-20-023620.md) | [0.1](/filings/0001437749-25-017064.md) | [1.2](/filings/0001437749-25-026970.md) | [1.2](/filings/0001437749-25-033852.md) | [1.1](/filings/0001437749-26-017406.md) | [1.2](/filings/0001437749-26-025065.md) | [1.2](/filings/0001437749-26-033940.md) | [166](/filings/0001437749-26-017406.md) | [31.0](/filings/0001437749-26-025065.md) | [221](/filings/0001437749-26-033940.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 73,117,016 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0001437749-26-033940.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:47 ET. No prices; not investment advice.